The impact of tovorafenib on tumor growth was assessed in two different NF1-LOF mutant models, including an NF1-LOF mutant ERMS PDX model and an NF1-LOF melanoma xenograft tumor model, MeWo. This evidence concerns the gene NF1 and melanoma.